CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-02 | Cowan Elvia SVP, FINANCE | Shares withheld for taxes 10b5-1 | −324 | $71.55 | $23K | 12,156 |
| 2024-03-02 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes 10b5-1 | −613 | $71.55 | $44K | 30,597 |
| 2024-03-02 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −3,795 | $71.55 | $272K | 95,679 |
| 2024-03-02 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Shares withheld for taxes 10b5-1 | −7,967 | $71.55 | $570K | 412,847 |
| 2024-03-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,017 | $73.08 | $74K | 222,835 |
| 2024-03-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,220 | $73.62 | $90K | 221,615 |
| 2024-03-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −763 | $74.70 | $57K | 220,852 |
| 2024-03-01 | Cowan Elvia SVP, FINANCE | Option exercise 10b5-1 | +11,000 | $25.92 | $285K | 24,158 |
| 2024-03-01 | Cowan Elvia SVP, FINANCE | Sale 10b5-1 | −2,322 | $73.08 | $170K | 21,836 |
| 2024-03-01 | Cowan Elvia SVP, FINANCE | Sale 10b5-1 | −4,455 | $73.69 | $328K | 17,381 |
| 2024-03-01 | Cowan Elvia SVP, FINANCE | Sale 10b5-1 | −4,901 | $74.90 | $367K | 12,480 |
| 2024-03-01 | Cowan Elvia SVP, FINANCE | Option exercise · Stock Option (right to buy) 10b5-1 | −11,000 | 129,000 | ||
| 2024-03-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +1,667 | $21.41 | $36K | 32,877 |
| 2024-03-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −519 | $73.03 | $38K | 32,358 |
| 2024-03-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −703 | $73.59 | $52K | 31,655 |
| 2024-03-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −445 | $74.77 | $33K | 31,210 |
| 2024-03-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 189,999 | ||
| 2024-03-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −506 | $73.04 | $37K | 149,472 |
| 2024-03-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −439 | $73.54 | $32K | 149,033 |
| 2024-03-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −363 | $74.69 | $27K | 148,670 |
Page 31 of 39 · 764 trades